C. Patrick Machado
Retired Chief Financial Officer and Chief Business
chief financial officer
Mr. Machado is a co-founder of Medivation and served as chief financial officer of Medivation Neurology since its inception in September 2003. He became chief financial officer of Medivation, Inc., when the Company acquired its subsidiary Medivation Neurology, Inc. in December 2004 and became chief business officer in December 2009. Mr. Machado retired from Medivation in April 2014. From 1998 until 2001, Mr. Machado was employed by Pro-Duct Health, Inc., a privately held medical device company, as vice president, chief financial officer and general counsel (1998-2000) and as senior vice president and chief financial officer (2000-2001). From 2001 until 2002, Mr. Machado served as a consultant to Cytyc Corporation to assist with transitional matters related to Cytyc Corporation's acquisition of Pro-Duct Health, Inc. Mr. Machado received a J.D. from Harvard Law School and a B.A. and B.S. in German and Economics, respectively, from Santa Clara University. Mr. Machado serves on the board and audit committee of Chimerix, Inc, a publicly traded biopharmaceutical company, and is chair of the board of Armaron Bio Pty Ltd, a privately held biopharmaceutical company.